ロード中...
Long‐Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open‐Label Extension Study
OBJECTIVE: To investigate long‐term safety and tolerability of anifrolumab, a human monoclonal antibody to the type I interferon (IFN) receptor subunit 1, in patients with moderate‐to‐severe systemic lupus erythematosus (SLE). METHODS: This 3‐year, multinational, open‐label extension study included...
保存先:
| 出版年: | Arthritis Rheumatol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8252065/ https://ncbi.nlm.nih.gov/pubmed/33225631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41598 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|